---
title: "FIBK: Q2 2026 net income surged 39% year-over-year, aided by branch sales and margin gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293662193.md"
description: "Net income rose to $83.9 million in Q2 2026, driven by improved net interest margin and a $19.5 million gain from branch sales. Share repurchases and dividends continued, while capital ratios and efficiency improved.Original document: First Interstate BancSystem, Inc. [FIBK] SEC 8-K Current Report — Jul. 24 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-23T20:18:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293662193.md)
  - [en](https://longbridge.com/en/news/293662193.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293662193.md)
generator: "portal-rs"
---

# FIBK: Q2 2026 net income surged 39% year-over-year, aided by branch sales and margin gains

Net income rose to $83.9 million in Q2 2026, driven by improved net interest margin and a $19.5 million gain from branch sales. Share repurchases and dividends continued, while capital ratios and efficiency improved.

Original document: First Interstate BancSystem, Inc. \[FIBK\] SEC 8-K Current Report — Jul. 24 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [FIBK.US](https://longbridge.com/en/quote/FIBK.US.md)

## Related News & Research

- [First Interstate BancSystem, Inc. $FIBK Shares Sold by Wedge Capital Management L L P NC](https://longbridge.com/en/news/295997317.md)
- [DUOT: Q2 2026 revenue up 30%, gross margin up 94%, and positive adjusted EBITDA achieved](https://longbridge.com/en/news/296141671.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [Is Tenable Holdings (TENB) Fairly Valued Following Its Expanded AI Security Push?](https://longbridge.com/en/news/296139577.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**